Thursday, September 1, 2016

BRIEF-Cytokinetics and Amgen to advance Omecamtiv Mecarbil to phase 3

* Cytokinetics and Amgen to advance Omecamtiv Mecarbil to

phase 3 clinical development

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)